Oncothyreon to Present at Future Leaders in the Biotech Industry Conference

 Oncothyreon to Present at Future Leaders in the Biotech Industry Conference

PR Newswire

SEATTLE, WA, March 29, 2013

SEATTLE, WA, March 29, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY)
announced today that Robert Kirkman, M.D., President and Chief Executive
Officer, will present at the 20^th Annual Future Leaders in the Biotech
Industry Conference, presented by BioCentury and Thomson Reuters, in New York
on Friday, April 5, 2013 at 10:30 a.m. Eastern time.

A live and archived webcast of the presentation will be accessible by visiting
the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.

Contact:

Investor and Media Relations Contact:
Julie Rathbun
Rathbun Communications
206-769-9219
ir@oncothyreon.com
 
Press spacebar to pause and continue. Press esc to stop.